Drug Discovery
Sartorius and TheWell Bioscience Partner to Enable More Accurate Predictions in Drug Discovery
Solutions address shift from animal-based to more human-relevant organoid models, resulting in more accurate predictions in drug discovery Synergies wit...
April 10, 2024 | News
RemeGen's Telitacicept Secures FDA Fast Track Status for Primary Sjögren's Syndrome Treatment
RemeGen , a commercial-stage biotechnology company, obtained Fast Track Designation (FTD) by the United States Food and Drug Administration (FDA) rec...
April 03, 2024 | News
Innovent and HUTCHMED's Endometrial Cancer Therapy Receives Priority Review by China's NMPA
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...
April 03, 2024 | News
Alebund Pharmaceuticals Receives FDA Orphan Drug Designation for AP303 in ADPKD Treatment
Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for th...
April 01, 2024 | News
Hoth Therapeutics' Merveille.ai Achieves Breakthrough in Obesity Treatment with AI-Driven Therapeutic Candidate
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, is excited to announce a significant breakthrough by its sub...
March 28, 2024 | News
TiumBio Initiates Phase 1b Trial for New Hemophilia Treatment TU7710
TiumBio Co., Ltd., a trailblazer in the biopharmaceutical landscape, dedicated to crafting groundbreaking therapies for rare and untreatabl...
March 27, 2024 | News
DigmBio's Breakthrough Cancer Drug Clears Korean Regulatory Hurdle
BioDuro-Sundia's partner, DigmBio, a South Korean biotechnology company, announced its selective PARP1 inhibitor for the treatment of triple-negative breas...
March 26, 2024 | News
Takeda Receives FDA Approval for ICLUSIG as a First-Line Treatment in Ph+ ALL
Takeda Receives FDA Approval for ICLUSIG as a First-Line Treatment in Ph+ ALL Takeda Pharmaceutical Company Limited (TSE: 4502; NYSE: TAK) is plea...
March 25, 2024 | News
AriBio Secures Exclusive $770M Deal for Alzheimer's Drug in China
AriBio Co., Ltd. (AriBio), announces signing of exclusive marketing rights for AR1001, an investigational drug for early Alzheimer’s disease, in Chin...
March 25, 2024 | News
Vertex Pharmaceuticals Receives FDA Clearance for Innovative ADPKD Drug Trial
Vertex Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug Application (IND) f...
March 22, 2024 | News
Oscotec Inc. Gains FDA Orphan Drug Designation for Promising ITP Treatment Cevidoplenib
Oscotec Inc. has secured orphan drug designation (ODD) from the U.S. Food and Drug Administration (FDA) for its SYK inhibitor, Cevidoplenib, to treat immun...
March 22, 2024 | News
Antengene Advances ATG-022 in Phase II CLINCH Study for Solid Tumors in China and Australia,
Antengene Corporation Limited, a prominent global biopharmaceutical entity focused on the development and commercialization of pion...
March 21, 2024 | News
Takeda Achieves Groundbreaking FDA Approval for ICLUSIG® in Treating Newly Diagnosed Ph+ ALL Patients
This approval marks a pioneering step in treating adult patients with newly diagnosed Philadelphia chromosome-positive (Ph+) ALL, offering a combination th...
March 20, 2024 | News
Cognizant and NVIDIA Accelerate Drug Discovery with Generative AI
Cognizant (NASDAQ: CTSH) is advancing the application of generative AI (gen AI) technology with the NVIDIA BioNeMo platform to solve complex chal...
March 20, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
